Mastrangelo, G., Pavanello, S., Fadda, E., Buja, A., & Fedeli, U. (2018). Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: An observational study. Eur J Cancer Prev.

Mastrangelo, Giuseppe, Sofia Pavanello, Emanuela Fadda, Alessandra Buja, e Ugo Fedeli. "Yellow Fever Vaccine 17D Administered to Healthy Women Aged between 40 and 54 Years Halves Breast Cancer Risk: An Observational Study." Eur J Cancer Prev 2018.

Mastrangelo, Giuseppe, et al. "Yellow Fever Vaccine 17D Administered to Healthy Women Aged between 40 and 54 Years Halves Breast Cancer Risk: An Observational Study." Eur J Cancer Prev 2018.